Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-10-100950
Filing Date
2010-11-04
Accepted
2010-11-04 16:30:46
Documents
10
Period of Report
2010-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q b82686e10vq.htm 10-Q 382934
2 EX-31.1 b82686exv31w1.htm EX-31.1 7848
3 EX-31.2 b82686exv31w2.htm EX-31.2 7893
4 EX-32.1 b82686exv32w1.htm EX-32.1 4100
  Complete submission text file 0000950123-10-100950.txt   2099417

Data Files

Seq Description Document Type Size
5 EX-101 INSTANCE DOCUMENT alks-20100930.xml EX-101.INS 253933
6 EX-101 SCHEMA DOCUMENT alks-20100930.xsd EX-101.SCH 11693
7 EX-101 CALCULATION LINKBASE DOCUMENT alks-20100930_cal.xml EX-101.CAL 33743
8 EX-101 LABELS LINKBASE DOCUMENT alks-20100930_lab.xml EX-101.LAB 121548
9 EX-101 PRESENTATION LINKBASE DOCUMENT alks-20100930_pre.xml EX-101.PRE 79314
10 EX-101 DEFINITION LINKBASE DOCUMENT alks-20100930_def.xml EX-101.DEF 32403
Mailing Address 852 WINTER STREET WALTHAM MA 02451-1420
Business Address 852 WINTER STREET WALTHAM MA 02451-1420 (781)609-6000
ALKERMES INC (Filer) CIK: 0000874663 (see all company filings)

EIN.: 232472830 | State of Incorp.: PA | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-14131 | Film No.: 101165332
SIC: 2834 Pharmaceutical Preparations